The decision to fund 400 new medical residency positions at hospitals across the U.S. marks a meaningful -- though limited -- step toward addressing a looming physician shortage expected to worsen ...
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...
The Centers for Medicare & Medicaid Services has tapped ID.me to verify the identities of beneficiaries on Medicare.gov, according to a Tuesday announcement from the identity-proofing company. ID.me ...
On November 25, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that puts forth policy and technical changes to the Medicare Advantage (MA) and Part D programs for 2027 ...
For the millions of retired Americans who count on Medicare to help cover their health care costs, 2026 is shaping up to be an expensive year. While Social Security recipients are set to receive a ...
The Center for Medicare and Medicaid Services (CMS) Innovation Center has launched ACCESS, a model that expands access to technology-supported care for individuals on Original Medicare with obesity, ...
CMS plans to open applications in 2026 for a new payment model aimed at increasing access to technology-supported care for people with Original Medicare who are managing chronic conditions. Here are ...
The Trump administration has negotiated lower prices for 15 widely used medications covered by Medicare, with the federal government saying the effort will cut spending on those drugs by 44%, or about ...
The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...
The U.S. has revealed price reductions for the second round of prescription drugs negotiated by the Centers for Medicare & Medicaid Services (CMS) through the Inflation Reduction Act (IRA). Headlining ...
The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription drugs, including popular weight-loss medications Ozempic and Wegovy, asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results